Come dive into one of the curiously delightful conversations overheard at National Geographic’s headquarters, as we follow explorers, photographers, and scientists to the edges of our big, weird, beautiful world. Hosted by Peter Gwin and Amy Briggs.
…
continue reading
Kandungan disediakan oleh Oleksandr Yagensky. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Oleksandr Yagensky atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !
Pergi ke luar talian dengan aplikasi Player FM !
Ep#030: Using iPSCs to Discover New Therapies for Neurodegenerative Disorders with Professor Evangelos Kiskinis
MP3•Laman utama episod
Manage episode 301257884 series 2800366
Kandungan disediakan oleh Oleksandr Yagensky. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Oleksandr Yagensky atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
On this episode we take a look at the role induced Pluripotent Stem Cells (iPSCs) are playing in drug discovery and development for neurodegenerative diseases. Our host Oleksandr sat down with Professor Evangelos Kiskinis, who is leading his own research group at the Northwestern University in Chicago. Evangelos and his team are leading the way on the development of novel cell-based models for ALS, epilepsy and other types of neurological conditions.
Check out this episode to learn more about:
◦ Evangelos’s career story and what got him excited in stem cell research
◦ Challenges in modeling neurodegenerative diseases in a dish
◦ iPSC based models for inherited vs sporadic diseases
◦ Transitioning promising in vitro discoveries into clinical trials
◦ iPSC based cell replacement therapies for Parkinsons and Alzheimers disease
◦ The future of iPSC based models in drug discovery
◦ Evangelos’s advice to young scientists pursuing academic career
◦ Get in touch with Evangelos:
◦ LinkedIn: Evangelos Kiskinis
◦ Web: http://evangeloskiskinislab.org/index.html
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
…
continue reading
Check out this episode to learn more about:
◦ Evangelos’s career story and what got him excited in stem cell research
◦ Challenges in modeling neurodegenerative diseases in a dish
◦ iPSC based models for inherited vs sporadic diseases
◦ Transitioning promising in vitro discoveries into clinical trials
◦ iPSC based cell replacement therapies for Parkinsons and Alzheimers disease
◦ The future of iPSC based models in drug discovery
◦ Evangelos’s advice to young scientists pursuing academic career
◦ Get in touch with Evangelos:
◦ LinkedIn: Evangelos Kiskinis
◦ Web: http://evangeloskiskinislab.org/index.html
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
48 episod
MP3•Laman utama episod
Manage episode 301257884 series 2800366
Kandungan disediakan oleh Oleksandr Yagensky. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Oleksandr Yagensky atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
On this episode we take a look at the role induced Pluripotent Stem Cells (iPSCs) are playing in drug discovery and development for neurodegenerative diseases. Our host Oleksandr sat down with Professor Evangelos Kiskinis, who is leading his own research group at the Northwestern University in Chicago. Evangelos and his team are leading the way on the development of novel cell-based models for ALS, epilepsy and other types of neurological conditions.
Check out this episode to learn more about:
◦ Evangelos’s career story and what got him excited in stem cell research
◦ Challenges in modeling neurodegenerative diseases in a dish
◦ iPSC based models for inherited vs sporadic diseases
◦ Transitioning promising in vitro discoveries into clinical trials
◦ iPSC based cell replacement therapies for Parkinsons and Alzheimers disease
◦ The future of iPSC based models in drug discovery
◦ Evangelos’s advice to young scientists pursuing academic career
◦ Get in touch with Evangelos:
◦ LinkedIn: Evangelos Kiskinis
◦ Web: http://evangeloskiskinislab.org/index.html
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
…
continue reading
Check out this episode to learn more about:
◦ Evangelos’s career story and what got him excited in stem cell research
◦ Challenges in modeling neurodegenerative diseases in a dish
◦ iPSC based models for inherited vs sporadic diseases
◦ Transitioning promising in vitro discoveries into clinical trials
◦ iPSC based cell replacement therapies for Parkinsons and Alzheimers disease
◦ The future of iPSC based models in drug discovery
◦ Evangelos’s advice to young scientists pursuing academic career
◦ Get in touch with Evangelos:
◦ LinkedIn: Evangelos Kiskinis
◦ Web: http://evangeloskiskinislab.org/index.html
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com
48 episod
Усі епізоди
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.